Marc Scheineson comments on the new Cures Act directing the U.S. Food and Drug Administration to approve drugs and devices with greater urgency.
In the News
December 12, 2016
Science | Under 21st Century Cures Legislation, Stem Cell Advocates Expect Regulatory Shortcuts
Media Contact